Photo from wikipedia
A high prevalence of cancers in metabolic disorders, like metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM), recently has been noted, including prostate cancer (PC), which is androgen‐sensitive. However,… Click to show full abstract
A high prevalence of cancers in metabolic disorders, like metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM), recently has been noted, including prostate cancer (PC), which is androgen‐sensitive. However, the pathological relationship among testosterone and insulin and insulin‐like growth factor (IGF)‐1 signaling in relation to MetS and T2DM with PC remains unclear.
Keywords:
insulin;
impact metabolic;
prostate cancer;
metabolic disorders;
growth
Journal Title: Reproductive Medicine and Biology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Reproductive Medicine and Biology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!